Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade

By Investor's Business Daily | Oct 15, 2024 at 02:10 PM EST

Amphastar Pharmaceuticals is a successful drugmaker with a wide range of drugs, showing strong stock performance and growth potential. It offers a diverse portfolio of medications, including innovative products like Baqsimi. With robust earnings and revenue growth, it is a top performer in the industry.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.